Scilex Holding (SCLXW) Receivables (2021 - 2026)

Scilex Holding (SCLXW) recorded quarterly Receivables of $19.2 million in Q1 2026, up 60.79% quarter-over-quarter from $11.9 million in Q3 2025, and up 80.81% on a YoY basis from $10.6 million in Q1 2025.

Scilex Holding (SCLXW) Receivables (2021 - 2026) Analysis & Trends

Scilex Holding's Receivables history runs 6 years deep, the most recent figure standing at $19.2 million for Q1 2026.

  • In Q1 2026, Receivables rose 80.81% year-over-year to $19.2 million; the TTM figure through Mar 2026 stood at $19.2 million (up 80.81% YoY), while the FY2024 annual figure was $26.4 million, up 726.31% from the prior year.
  • Receivables was $19.2 million for Q1 2026 at Scilex Holding, up from $11.9 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $38.0 million in Q2 2024 to a low of $6.4 million in Q1 2023.
  • Historically, Receivables has averaged $22.3 million across 5 years, with a median of $21.2 million in 2022.
  • The sharpest annual moves came in 2024 and 2025: Receivables jumped 364.31% in 2024, then sank 64.27% in 2025.
  • A 5-year view of Receivables shows it stood at $21.2 million in 2022, then jumped by 62.92% to $34.6 million in 2023, then decreased by 23.57% to $26.4 million in 2024, then slumped by 54.84% to $11.9 million in 2025, then soared by 60.79% to $19.2 million in 2026.
  • The last three Receivables figures came in at $19.2 million (Q1 2026), $11.9 million (Q3 2025), and $16.8 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn 10.46 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 21.18 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 17.72 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 12.48 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 12.21 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn 9.14 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 5.33 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn 12.59 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn 9.52 Bn
10 Scilex Holding - - 4.15 Mn 19.20 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 19.20 Mn
Sep 30, 2025 11.94 Mn
Jun 30, 2025 16.77 Mn
Mar 31, 2025 10.62 Mn
Dec 31, 2024 26.44 Mn
Sep 30, 2024 31.58 Mn
Jun 30, 2024 38.00 Mn
Mar 31, 2024 29.72 Mn
Dec 31, 2023 34.60 Mn
Sep 30, 2023 16.43 Mn
Jun 30, 2023 27.57 Mn
Mar 31, 2023 6.40 Mn
Dec 31, 2022 21.24 Mn
Dec 31, 2021 14.27 Mn